Multidimensional evaluation of drug users and the Addiction Severity Index;Avaliação multidimensional do usuário de drogas e a Escala de Gravidade de Dependência

Revista de Psiquiatria do Rio Grande do Sul

Volumn 32, Issue 2, 2010, Pages 48-56

  Kessler, Felix Henrique Paim ^a   Faller, Sibele ^a   Souza Formigoni, Maria Lucia O ^b   Cruz, Marcelo Santos ^c   Brasiliano, Sílvia ^d   Stolf, Anderson Ravy ^a   Pechansky, Flavio ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Alcoholism; Diagnosis of health situation; Substance related disorders

Indexed keywords

ADDICTION; ADDICTION SEVERITY INDEX; ARTICLE; DATA BASE; DISEASE SEVERITY; DRUG USE; EVALUATION; HEALTH CARE SYSTEM; HUMAN; LILACS; MEDLINE; PSYCINFO; PUBLIC HEALTH;

BRAZIL; CROSS-SECTIONAL STUDIES; DELIVERY OF HEALTH CARE; PRIMARY HEALTH CARE; QUALITY OF HEALTH CARE;

EID: 77957231247     PISSN: 01018108     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0101-81082010000200005     Document Type: Article

References (91)

1. Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroine and cocaine dependence. Am J Psychiatry. 1985;142:1259-64.
2. McLellan A, Luborsky L, Woody G, OBrien C. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis. 1980;168(1):26-33.
3. McLellan AT, Cacciola J, Alterman A, Rikoon S, Carise D. The Addiction Severity Index at 25: origins, contributions and transitions. Am J Addict. 2006;15(2):113-24.
4. Kessler FHP. Adaptação transcultural multicêntrica da sexta versão da Escala de Gravidade de Dependência (ASI6) para o Brasil. Rev Psiquiatr Rio Gd Sul. 2007;29(3):335-6.
5. Kessler F, Woody G, De Boni R, Von Diemen L, Benzano D, Faller S, et al. Evaluation of psychiatric symptoms in cocaine users in the Brazilian public health system: need for data and structure. Public Health. 2008;122(12):1349-55.
6. Paton W. Drug dependence: a socio-pharmacological assessment. Adv Sci. 1968;25(124):200-12.
7. Louria D. Drug abuse: a current assessment. Am Fam Physician GP. 1970;1(6):74-80.
8. Morselli P, Placidi G, Maggini C, Gomeni R, Guazelli M, De Lisio G, et al. An integrated approach for the evaluation of psychotropic drug in man. I. Studies on amphetamine. Relationship between drug levels and psychophysiological measurements. Psychopharmacologia. 1976;46(2):211-7.
9. Carroll J, Malloy T, Kenrick F. Drug abuse by alcoholics and problem drinkers: a literature review and evaluation. Am J Drug Alcohol Abuse. 1977;4(3):317-41.
10. Holsten F, Waal H. Evaluation of the drug taker. A step to an evaluation of treatment. Acta Psychiatr Scand Suppl. 1980;284:29-41.
11. Gitlow S. Considerations on the evaluation and treatment of substance dependency. J Subst Abuse Treat. 1985;2(3):175-9.
12. Stacy AW, Widaman KF, Hays R, DiMatteo MR. Validity of self-reports of alcohol and other drug use: a multitrait-multimethod assessment. J Pers Soc Psychol. 1985;49(1):219-32.
13. Castillo Pérez P. [Ethical aspects of drug evaluation in human beings]. Rev Clin Esp. 1986;179(1):42-9.
14. Hasin D, Grant B. Assessment of specific drug disorders in a sample of substance abuse patients: a comparison of the DIS and the SADS-L procedures. Drug Alcohol Depend. 1987;19(2):165-76.
15. Stein J, Newcomb M, Bentler P. Structure of drug use behaviors and consequences among young adults: multitrait-multimethod assessment of frequency, quantity, work site, and problem substance use. J Appl Psychol. 1988;73(4):595-605.
16. Sweeney J, Meisel L, Walsh V, Castrovinci D. Assessment of cognitive functioning in poly-substance abusers. J Clin Psychol. 1989;45(2):346-51.
17. Richardson H. Volatile substance abuse: evaluation and treatment. Hum Toxicol. 1989;8(4):319-22.
18. Nuckols C, Greenson J. Cocaine addiction. Assessment and intervention. Nurs Clin North Am. 1989;24(1):33-43.
19. Kauffman J, Shaffer H, Burglass M. A strategy for the biological assessment of addiction. Adv Alcohol Subst Abuse. 1983-1984 Fall-Winter;3(1-2): 7-18.
20. Gaulier B, Butler S, Haller D. Problems associated with the assessment of personality disorders in substance abusers. NIDA Res Monogr. 1990;105:599-600.
21. Fagerstrom K, Heatherton T, Kozlowski L. Nicotine addiction and its assessment. Ear Nose Throat J. 1990;69(11):763-5.
22. McLellan A, Randall M, Joseph N, Alterman A. Categorizing substance abusers using the ASI: implications for evaluation and treatment. NIDA Res Monogr. 1990;105:227-35.
23. Butler S, Gaulier B, Haller D. Assessment of axis II personality disorders among female substance abusers. Psychol Rep. 1991;68(3 Pt 2):1344-6.
24. Bigelow G. Human drug abuse liability assessment: opioids and analgesics. Br J Addict. 1991;86(12):1615-23.
25. Lisanti P. Assessment of the adult client for drug and alcohol use. NLN Publ. 1991(15-2407):151-247.
26. OHare T. The substance-abusing chronically mentally ill client: prevalence, assessment, treatment, and policy concerns. Soc Work. 1992;37(2):185-7.
27. Burns C. Assessment and screening for substance abuse: guidelines for the primary care nurse practitioner. Nurse Pract Forum. 1993;4(4):199-206.
28. Curtiss M, Lenz K, Frei N. Medical evaluation of African American women entering drug treatment. J Addict Dis. 1993;12(4):29-44.
29. Sees K, Clark H. Opioid use in the treatment of chronic pain: assessment of addiction. J Pain Symptom Manage. 1993;8(5):257-64.
30. Simeone R, Frank B, Aryan Z. Needs assessment in substance misuse: a comparison of approaches and case study. Int J Addict. 1993;28(8):767-92.
31. 33rd Annual Meeting of the New Clinical Drug Evaluation Unit (NCDEU). Boca Raton, Florida, June 1993. Proceedings and abstracts. Psychopharmacol Bull. 1994;30(1):1-141.
32. Altimir M, Serras E, Torrens M. [Detection and evaluation of drug addict patients seen at a primary care center]. Aten Primaria. 1994;13(5):252-4.
33. Frances R. Substance abuse in the general hospital. A priority area for evaluation and treatment. Gen Hosp Psychiatry. 1994;16(2):71-2.
34. Moore R. Screening and assessment of alcohol and other drug abuse. Md Med J. 1994;43(1):35-9.
35. Ross H, Swinson R, Larkin E, Doumani S. Diagnosing comorbidity in substance abusers. Computer assessment and clinical validation. J Nerv Ment Dis. 1994;182(10):556-63.
36. King C, Van Hasselt V, Segal D, Hersen M. Diagnosis and assessment of substance abuse in older adults: current strategies and issues. Addict Behav. 1994;19(1):41-55.
37. McHugo G, Caspi Y, Kammerer N, Mazelis R, Jackson E, Russell L, et al. The assessment of trauma history in women with co-occurring substance abuse and mental disorders and a history of interpersonal violence. J Behav Health Serv Res. 2005;32(2):113-27.
38. Carroll KM. Methodological issues and problems in the assessment of substance use. Psychol Assess. 1995;7(3):349-58.
39. Santolaria-Fernández F, Gómez-Sirvent J, González-Reimers C, Batista-López J, Jorge-Hernández J, Rodríguez-Moreno F, et al. Nutritional assessment of drug addicts. Drug Alcohol Depend. 1995;38(1):11-8.
40. Westermeyer J. Cultural aspects of substance abuse and alcoholism. Assessment and management. Psychiatr Clin North Am. 1995;18(3):589-605.
41. Moffett L, Steinberg S, Rohde P. Personality assessment of substance-dependent patients in a therapeutic community. J Subst Abuse Treat. 1996;13(2):127-34.
42. Vasconcelos T. [Substance dependence. Evaluation of risk and planning of care]. Servir. 1996;44(5):247-50.
43. Hiller ML, Knight K, Simpson DD. An assessment of comorbid psychological problems in a residential criminal justice drug treatment program. Psychol Addict Behav. 1996;10(3):181-9.
44. Wansi E, Sam-Abbenyi A, Befidi-Mengue R, Enyme F, Ntone F. Rapid assessment of drug abuse in Cameroon. Bull Narc. 1996;48(1-2):79-88.
45. Planeta CdS, Delucia R, Aizenstein ML. On the evaluation of drug dependence in experimental and clinical models. Rev Cienc Farm. 1997;18(2):187-95.
46. Blow F, Barry K, BootsMiller B, Copeland L, McCormick R, Visnic S. Longitudinal assessment of inpatient use and functioning of seriously mentally ill veterans with and without co-occurring substance use disorders. J Psychiatr Res. 1998;32(5):311-9.
47. Addiction. Screening, diagnosis, and assessment. Rep Group Adv Psychiatry. 1998(142):11-33.
48. Badr I, Farghaly A, Koura M, Mohamed H, Hassan E, Kotkat A. Health status assessment of drug addicts in Alexandria. J Egypt Public Health Assoc. 1998;73(3-4):275-96.
49. Mendelson J, Mello N. Diagnostic evaluation of alcohol and drug abuse problems in women. Psychopharmacol Bull. 1998;34(3):279-81.
50. Souza MAd. Funcionamento psicodinâmico em drogadictos através do Rorschach. Bol Psicol. 1998;48(108):1-12.
51. Evaluation of certain veterinary drug residues in food. Fiftieth report of the joint FAO/WHO Expert Committee on Food Additives. World Health Organ Tech Rep Ser. 1999;888:i-vii, 1-95.
52. Castel S, Formigoni MLOS. Escalas para avaliaçäo de tratamentos de dependência de alcool e outras drogas. Rev Psiquiatr Clin. 1999;26(1 especial):32-7.
53. Cooper D. Substance-use assessment. Prof Nurse. 1999;14(7):449.
54. Mosegui G, Rozenfeld S, Veras R, Vianna C. [Quality assessment of drug use in the elderly]. Rev Saude Publica. 1999;33(5):437-44.
55. Rouse SV, Butcher JN, Miller KB. Assessment of substance abuse in psychotherapy clients: The effectiveness of the MMPI-2 substance abuse scales. Psychol Assess. 1999;11(1):101-7.
56. Silva EAd, Formigoni MLOS. Avaliação do funcionamento familiar em farmacodependências. Rev Psiquiatr Clin. 1999;26(1 especial):38-40.
57. Smit E, Tang A. Nutritional assessment in intravenous drug users with HIV/AIDS. J Acquir Immune Defic Syndr. 2000;25 Suppl 1:S62-9.
58. Marlowe D, Merikle E, Kirby K, Festinger D, McLellan A. Multidimensional assessment of perceived treatment-entry pressures among substance abusers. Psychol Addict Behav. 2001;15(2):97-108.
59. Kan C, Breteler M, van der Ven A, Timmermans M, Zitman F. Assessment of benzodiazepine dependence in alcohol and drug dependent outpatients: a research report. Subst Use Misuse. 2001;36(8):1085-109.
60. Menninger J. Assessment and treatment of alcoholism and substance-related disorders in the elderly. Bull Menninger Clin. 2002;66(2):166-83.
61. Grohman K, Fals-Stewart W. The detection of cognitive impairment among substance-abusing patients: the accuracy of the neuropsychological assessment battery-screening module. Exp Clin Psychopharmacol. 2004;12(3):200-7.
62. Griffiths R, Bigelow G, Ator N. Principles of initial experimental drug abuse liability assessment in humans. Drug Alcohol Depend. 2003;70(3 Suppl):S41-54.
63. Oliveira ERNd, Marin IC, Ferruzzi L, Tenório MFS, Trindade E. Avaliação dos hábitos alimentares e dos dados antropométricos de dependentes químicos. Arq Cienc Saude Unipar. 2005;9(2):91-6.
64. Cardoso EdS, Pruett SR, Chan F, Tansey TN. Substance abuse assessment and treatment: the current training and practice of APA Division 22 members. Rehabil Psychol. 2006;51(2):175-8.
65. Funada M, Aoo N. [Evaluation of drug dependence: use of a conditioned place preference paradigm]. Nippon Yakurigaku Zasshi. 2007;130(2):128-33.
66. Vanem P, Krog D, Hartmann E. Assessment of substance abusers on the MCMI-III and the Rorschach. Scand J Psychol. 2008;49(1):83-91.
67. Degenhardt L, Bohnert K, Anthony J. Assessment of cocaine and other drug dependence in the general population: "gated" versus "ungated" approaches. Drug Alcohol Depend. 2008;93(3):227-32.
68. Brasiliano S. Fatores psicológicos no abuso e dependência de drogas. In: Andrade AG, Nicastri S, Tongue E, editores. Drogas: atualização em prevenção e tratamento. São Paulo: Lemos; 1993. p. 79-84.
69. Prochaska JO, DiClemente CC. Transtheoretical therapy: toward a more integrative model of change. Psychother Theory Res Pract. 1982;19(3):276-88.
70. Kessler FHP. Psicoterapias para o alcoolismo. In: Cordioli AV, organizador. Psicoterapias: abordagens atuais. Porto Alegre: Artmed; 2008. p. 585-99.
71. Laranjeira R. Como organizar uma história clínica. In: Figlie NB, editor. Aconselhamento em dependência química. São Paulo: Rocca; 2004.
72. de Azevedo R, Botega N, Guimarães L. Crack users, sexual behavior and risk of HIV infection. Rev Bras Psiquiatr. 2007;29(1):26-30.
73. Bastos F, Cunha C, Bertoni N. [Use of psychoactive substances and contraceptive methods by the Brazilian urban population, 2005]. Rev Saude Publica. 2008;42 Suppl 1:118-26.
74. Nappo S, Sanchez Z, Oliveira L, Santos S, Coradete Jr J, Pacca J, et al. Comportamento de risco de mulheres usuárias de crack em relação às DST/AIDS. São Paulo: Centro Brasileiro de Informações sobre Drogas Psicotrópicas; 2004.
75. Nuttbrock L, Rosenblum A, Magura S, Villano C, Wallace J. Linking female sex workers with substance abuse treatment. J Subst Abuse Treat. 2004;27(3):233-9.
76. Morawska J, Satora L. [Assessment of the legal awareness regarding drug consumption]. Przegl Lek. 2004;61(4):328-31.
77. da Costa J, de Sousa M, Magalhaes T, Ribeiro C, Grams A, Ramon J, et al. Assessment of drug addiction. The experience of the Medico Legal Institute of Oporto. Med Law. 2000;19(2):309-19.
78. Zilberman M, Blume S. [Domestic violence, alcohol and substance abuse]. Rev Bras Psiquiatr. 2005;27 Suppl 2:S51-5.
79. da Silva Lima A, Fleck M, Pechansky F, de Boni R, Sukop P. Psychometric properties of the World Health Organization quality of life instrument (WHOQoL-BREF) in alcoholic males: a pilot study. Qual Life Res. 2005;14(2):473-8.
80. da Silva Lima A, Fleck M. Qualidade de vida e alcoolismo. In: Fleck M, editor. A avaliação da qualidade de vida: guia para profissionais de saúde. Porto Alegre: Artmed; 2008. p. 115-122.
81. Kessler R. The epidemiology of dual diagnosis. Biol Psychiatry. 2004;56(10):730-7.
82. Salloum IM. Issues in dual diagnosis [Internet]. MedscapeCME, Accreditation Council for Continuing Medical Education; 2005. Available from: http://cme. medscape.com/viewarticle/507192
83. Lehman A, Myers C, Corty E. Assessment and classification of patients with psychiatric and substance abuse syndromes. 1989. Psychiatr Serv. 2000;51(9):1119-25.
84. Trezza G, Popp S. The substance user at risk of harm to self or others: assessment and treatment issues. J Clin Psychol. 2000;56(9):1193-205.
85. Kubarych TS, Aggen SH, Hettema JM, Kendler KS, Neale MC. Assessment of generalized anxiety disorder diagnostic criteria in the National Comorbidity Survey and Virginia Adult Twin Study of Psychiatric and Substance Use Disorders. Psychol Assess. 2008;20(3):206-16.
86. Grilo C, Becker D, Anez L, McGlashan T. Diagnostic efficiency of DSM-IV criteria for borderline personality disorder: an evaluation in Hispanic men and women with substance use disorders. J Consult Clin Psychol. 2004;72(1):126-31.
87. Bischof G, Rumpf H, Meyer C, Hapke U, John U. Influence of psychiatric comorbidity in alcohol-dependent subjects in a representative population survey on treatment utilization and natural recovery. Addiction. 2005;100(3):405-13.
88. Drake R, ONeal E, Wallach M. A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. J Subst Abuse Treat. 2008;34(1):123-38.
89. Flynn P, Brown B. Co-occurring disorders in substance abuse treatment: issues and prospects. J Subst Abuse Treat. 2008;34(1):36-47.
90. Dougherty D, Mathias C, Marsh D, Moeller F, Swann A. Suicidal behaviors and drug abuse: impulsivity and its assessment. Drug Alcohol Depend. 2004;76 Suppl: S93-105.
91. Formigoni ML, Castel S. Escalas de avaliação de dependência de drogas: aspectos gerais. Rev Bras Psiquiatr. 1999;26(1)5-31.